A recent phase 3 clinical trial has confirmed that subcutaneous anifrolumab, marketed as Saphnelo,...
Lupus
In an extraordinary celestial event, two exploding stars, V462 Lupi and V572 Velorum, are...
Breaking News & Top Stories